Viewing Study NCT06138769

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:55 PM
Ignite Modification Date: 2026-06-20 @ 4:36 AM
Study NCT ID: NCT06138769
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-07-03
First Post: 2023-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
Sponsor: Asan Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hepatocellular carcinoma View
None lenvatinib View
None atezolizumab-bevacizumab View